• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Expert opinion on therapeutic targets >Cancer vaccines.
【24h】

Cancer vaccines.

机译：癌症疫苗。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Cancer vaccines - a dream or a reality? There is no doubt that a time will come when this new approach to cancer treatment will provide opportunities that will be both complementary and synergistic with existing treatments. Novelty is often linked to risk, and if there is a given medical field that desperately needs therapeutic improvement, cancer is it. Recent advances on the understanding of the functioning and manipulation of the immune system and on the host-tumour relationship, and on tumour escape, will soon pay off. However, the development of cancer vaccines is not an easy undertaking and the multitude of obstacles are presented and reviewed in this article. The cancer vaccine 'detractors' that are arguing negatively on the chances of success are, to this date, correct. Nevertheless, a parallel could be drawn from the monoclonal antibodies, which have suffered from a long and difficult history, to hold promise in man. Recent technological progress has once again demonstrated that one can eventually bypass the commonly accepted barriers, as there are now monoclonal-based products currently helping patients. The entire oncology community is eagerly awaiting the next chapter in the cancer vaccine story.
机译：癌症疫苗-梦想还是现实？毫无疑问，这种新的癌症治疗方法将提供与现有治疗相辅相成和协同作用的机会。新颖性通常与风险相关，如果在某个医学领域急需改善治疗方法，那就是癌症。在了解免疫系统功能和操纵，宿主与肿瘤之间的关系以及肿瘤逃逸方面的最新进展将很快获得回报。但是，开发癌症疫苗并非易事，本文提出并审查了许多障碍。迄今为止，对成功机会持否定态度的癌症疫苗“贬低者”是正确的。然而，可以从单克隆抗体中获得相似的结果，因为它们具有悠久而艰难的历史，有望在人类中大放异彩。最近的技术进步再次表明，人们最终可以绕过普遍接受的障碍，因为现在有基于单克隆的产品正在帮助患者。整个肿瘤学界都在热切期待癌症疫苗故事的新篇章。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号